Literature DB >> 29856554

"Will I need to take these medications for the rest of my life?"

Stephen R Marder1, Michael F Zito1.   

Abstract

Year:  2018        PMID： 29856554      PMCID： PMC5980574          DOI： 10.1002/wps.20519

Source DB:  PubMed          Journal:  World Psychiatry        ISSN： 1723-8617            Impact factor:   49.548


× No keyword cloud information.
  6 in total

1.  Testing definitions of symptom remission in first-episode psychosis for prediction of functional outcome at 2 years.

Authors:  Clifford M Cassidy; Ross Norman; Rahul Manchanda; Norbert Schmitz; Ashok Malla
Journal:  Schizophr Bull       Date:  2009-03-25       Impact factor: 9.306

Review 2.  Beyond Clinical Remission in First Episode Psychosis: Thoughts on Antipsychotic Maintenance vs. Guided Discontinuation in the Functional Recovery Era.

Authors:  M Alvarez-Jimenez; B O'Donoghue; A Thompson; J F Gleeson; S Bendall; C Gonzalez-Blanch; E Killackey; L Wunderink; P D McGorry
Journal:  CNS Drugs       Date:  2016-05       Impact factor: 5.749

3.  Medication adherence in outpatients with severe mental disorders: relation between self-reports and serum level.

Authors:  Halldóra Jónsdóttir; Stein Opjordsmoen; Astrid B Birkenaes; John A Engh; Petter Andreas Ringen; Anja Vaskinn; Trond O Aamo; Svein Friis; Ole A Andreassen
Journal:  J Clin Psychopharmacol       Date:  2010-04       Impact factor: 3.153

4.  Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals.

Authors:  Jennifer C Day; Richard P Bentall; Chris Roberts; Fiona Randall; Anne Rogers; Dinah Cattell; David Healy; Pam Rae; Cheryl Power
Journal:  Arch Gen Psychiatry       Date:  2005-07

5.  Fluphenazine vs placebo supplementation for prodromal signs of relapse in schizophrenia.

Authors:  S R Marder; W C Wirshing; T Van Putten; J Mintz; J McKenzie; K Johnston-Cronk; M Lebell; R P Liberman
Journal:  Arch Gen Psychiatry       Date:  1994-04

6.  Predictors of treatment discontinuation and medication nonadherence in patients recovering from a first episode of schizophrenia, schizophreniform disorder, or schizoaffective disorder: a randomized, double-blind, flexible-dose, multicenter study.

Authors:  Diana O Perkins; Hongbin Gu; Peter J Weiden; Joseph P McEvoy; Robert M Hamer; Jeffrey A Lieberman
Journal:  J Clin Psychiatry       Date:  2008-01       Impact factor: 4.384
  6 in total
  3 in total

Review 1.  Achieving the Lowest Effective Antipsychotic Dose for Patients with Remitted Psychosis: A Proposed Guided Dose-Reduction Algorithm.

Authors:  Chen-Chung Liu; Hiroyoshi Takeuchi
Journal:  CNS Drugs       Date:  2020-02       Impact factor: 5.749

Review 2.  Guidelines for Discontinuation of Antipsychotics in Patients Who Recover From First-Episode Schizophrenia Spectrum Disorders: Derived From the Aggregated Opinions of Asian Network of Early Psychosis Experts and Literature Review.

Authors: 
Journal:  Int J Neuropsychopharmacol       Date:  2022-09-28       Impact factor: 5.678

3.  Mental Health Professionals' Attitudes Towards People with Severe Mental Illness: Are they Related to Professional Quality of Life?

Authors:  Katerina Koutra; Georgios Mavroeides; Sofia Triliva
Journal:  Community Ment Health J       Date:  2021-07-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.